Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06451172 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Study acronym: ASOTARI
StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 11, 2024 (before its estimated October 1, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The purpose of this study is to evaluate the safety and efficacy of GP-asPNA for in vivo treatment of severe antibiotic resistant bacterial keratitis.
Trial Details
NCT Number NCT06451172
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Soochow University
Conditions
(from sponsor)		 Bacterial Keratitis, Antibiotic-resistant Bacteria, Infections, Bacterial, Corneal Diseases, Eye Diseases, Vision Disorders, Sensation Disorders, Blindness +2 more
Related terms Bacterial Infections, Blindness, Corneal Diseases, Eye Diseases, Sensation Disorders, Vision Disorders
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov